Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents ; volume:7 ; number:1 ; day:15 ; month:10 ; year:2014 ; pages:1-8 ; date:12.2014
Journal of hematology & oncology ; 7, Heft 1 (15.10.2014), 1-8, 12.2014
- Creator
-
Parikh, Kaushal
Cang, Shundong
Sekhri, Arunabh
Liu, Delong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-014-0078-0
- URN
-
urn:nbn:de:101:1-2021082821191239480293
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Parikh, Kaushal
- Cang, Shundong
- Sekhri, Arunabh
- Liu, Delong
- SpringerLink (Online service)
Other Objects (12)
Heterocyclic anticancer agents
mTOR inhibitors: A novel class of anti-cancer agents
Novel selective anticancer agents based on Sn and Au complexes. Mini-review
Thiadiazole derivatives as anticancer agents
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Iridium compounds as prospective anti-cancer agents
Microcystins as Lead Structures for Anticancer Agents
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Selective amyloid-β lowering agents
Metallo-Drugs: development and action of anticancer agents
Recent updates on thienopyrimidine derivatives as anticancer agents
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Heterocyclic anticancer agents
mTOR inhibitors: A novel class of anti-cancer agents
Novel selective anticancer agents based on Sn and Au complexes. Mini-review
Thiadiazole derivatives as anticancer agents
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Iridium compounds as prospective anti-cancer agents
Microcystins as Lead Structures for Anticancer Agents
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Selective amyloid-β lowering agents
Metallo-Drugs: development and action of anticancer agents
Recent updates on thienopyrimidine derivatives as anticancer agents
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Heterocyclic anticancer agents
mTOR inhibitors: A novel class of anti-cancer agents
Novel selective anticancer agents based on Sn and Au complexes. Mini-review
Thiadiazole derivatives as anticancer agents
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Iridium compounds as prospective anti-cancer agents
Microcystins as Lead Structures for Anticancer Agents
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Selective amyloid-β lowering agents
Metallo-Drugs: development and action of anticancer agents
Recent updates on thienopyrimidine derivatives as anticancer agents